发明名称 |
MTKI QUINAZOLINE DERIVATIVES |
摘要 |
The present invention concerns the compounds of formula (I) the N-oxide f orms, the pharmaceutically acceptable addition salts and the stereochemicall y isomeric forms thereof, wherein Y represents -C3-9alkyl-, -C1-5alkyl-NR6-C 1-5alkyl- or -C1-5alkyl-NR7-CO-C1-5alkyl-; X1 represents -O-; X2 represents NR5-C1-2alkyl-; R1 represents hydrogen, halo or Het3-O-; R2 represents hydro gen; R3 represents hydroxy, C1-4alkyloxy- or C1-4alkyloxy subst ituted with one or two substituents each independently selected from Het4, hydroxy, C1-4 alkyloxy-, C1-4alkyloxy-C1-4alkyloxy and NR9R10; R5 represents hydrogen or C 1-4alkyl; R6 represents hydrogen or C1-4alkyl; R7 represents hydrogen; R9 an d R10 each independently represent hydrogen; C1-4alkyl-S(=O)2-C1-4alkyl-C(=O )-; C1-4alkyl or C1-4alkyl substituted with hydroxy; Het3 represents pyridin yl optionally substituted with C1-4alkyl; Het4 represents morpholinyl, piper idinyl or piperazinyl wherein said Het4 is optionally substituted with hydro xy-C1-4alkyl or C1-4alkyl-S(=O)2-C1-4alkyl-. |
申请公布号 |
CA2654583(A1) |
申请公布日期 |
2008.01.17 |
申请号 |
CA20072654583 |
申请日期 |
2007.07.12 |
申请人 |
JANSSEN PHARMACEUTICA N.V. |
发明人 |
TEN HOLTE, PETER;MEVELLEC, LAURENCE ANNE;EMBRECHTS, WERNER CONSTANT JOHAN;WILLEMS, MARC;PAPANIKOS, ALEXANDRA;STORCK, PIERRE-HENRI;FREYNE, EDDY JEAN EDGARD |
分类号 |
C07D498/14;A61K31/519;A61P35/00 |
主分类号 |
C07D498/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|